Novara Live UK Set To Cave To Trump On NHS Drug Prices
15 snips
Oct 8, 2025 Helena, a political commentator known as NoJusticeMTG, joins Nick Dearden, director of Global Justice Now, and economist James Meadway for an insightful discussion. They explore the implications of rising drug prices in the UK due to pressures from Trump's policies. Helena warns about the erosion of public sector skills by AI and consultancies, while Dearden advocates for public funding in pharmaceuticals. Meadway raises alarms over the potential economic fallout from an AI valuation collapse, linking it to broader financial risks.
AI Snips
Chapters
Books
Transcript
Episode notes
AI Spending Lacks Clear Productivity Payoff
- Most firms installing AI see little productivity gain, making current hype disproportionate to returns.
- Massive internal reinvestment and circular deals signal speculative valuation pumping.
Monitor AI Risk Within An ‘Everything’ Bubble
- Watch for knock‑on effects: an AI valuation fall could trigger broader market downturns.
- Treat AI as a systemic risk when markets are already stretched and demand fragile.
Consultancy Report Found To Contain Fake References
- Deloitte refunded part of A$440,000 after an Australian government report contained fabricated quotes and papers.
- The errors exposed AI-generated fabrications in a high‑paid consultancy deliverable.
